MeTA Goal and Strategy
     Goal: Equitable access to affordable essential 
      medicines in order to improve health outcomes
     Primary Objective 1: Increased transparency 
      – Disclosure and use of key pharmaceutical sector information 
      – Quality, availability, affordability, access, and use
     Primary Objective 2: Multi-stakeholder alliance
      – Support multi-stakeholder process
      – Strengthen governance and stakeholder accountability
    MeTA Country Activities During Pilot
     Develop and sustain national multi-stakeholder 
      alliance and activities
     Disclosure and use of key pharmaceutical data 
      – Public and private sector 
      – Medicine availability, affordability, quality, access, and use
     Applied research to address key questions
     Use of data for policy-making and advocacy
     Share experiences
     MeTA Toolbox
      Protocols and methods to assess and explore key aspects of 
       pharmaceutical system
       – Build on existing tools where they exist
       – Develop new tools to address key gaps
      Core tools to gain basic understanding of pharmaceutical sector 
       in pilot countries in relation to MeTA objectives
      Additional tools to guide priority processes identified by 
       stakeholder groups
      Tools to be available on MeTA website
      Technical support in implementation
     Role of Early Data Gathering
      Encourage use of core tools in pilot countries
       – Compile and synthesize existing information
       – Roster and summary of publicly available data
       – Community access to medicines
       – Foundation of country information portal
      Data for priority setting
       – Review by MeTA Stakeholder Group
       – Systematic consideration of sector-wide issues
       – Identify priority activities and future research
      Early data against which to measure progress
      Core Tool: Pharmaceutical Sector Scan
       Objective: To summarize key pharmaceutical sector data for review by 
         stakeholder group in order to identify priorities
       Many existing tools and databases
       Existing pharmaceutical sector data
         – Structures and processes
         – Legislation and regulation
         – Financing and expenditure
         – Market statistics
         – Therapeutic frameworks (e.g., essential medicines lists)
       Tools and templates to assemble data for review by MeTA stakeholder 
         group
       MeTA     03/09/22                                                                        6